Results from a First-in-Human Trial of a Novel Vascular Sealant

Results from a First-in-Human Trial of a Novel Vascular Sealant

Background:Suture hole bleeding from synthetic grafts presents a hemostatic challenge. The designs of many vascular sealants are not optimal (non-adherence to wet surfaces, excessive swelling, inflexible). PreveLeak™ (formerly ArterX) is a polyaldehyde-bovine serum albumin-based sealant whose effica...

Full description

Bibliographic Details
Main Authors: Hans Joachim Florek, Jan eBrunkwall, Karl Heinz Orend, Ian eHandley, John P. Pribble, Ronald eDieck
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-07-01
Series:Frontiers in Surgery
Subjects:
Hemostasis
Safety
efficacy evaluation
Vascular Surgery
albumin
Surgical sealant
Online Access:http://journal.frontiersin.org/Journal/10.3389/fsurg.2015.00029/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fsurg.2015.00029/full

Similar Items